Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
DMK Pharmaceuticals Corporation · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2027 | $50.11M | $50.11M - $50.11M | -$50.11M | $0.18 | 1 |
| Dec 2026 | $29.50M | $29.50M - $29.50M | -$29.50M | -$0.17 | 1 |
| Dec 2025 | $17.13M | $17.13M - $17.13M | -$17.13M | -$0.43 | 1 |
| Dec 2024 | $4.64M | $4.64M - $4.64M | -$4.64M | -$0.96 | 1 |
| Dec 2023 | $1.47M | $1.47M - $1.47M | -$1.47M | -$4.39 | 1 |
| Dec 2022 | $3.30M | $2.70M - $3.90M | -$3.30M | -$12.60 | 1 |
| Dec 2021 | $13.03M | $13.03M - $13.03M | -$13.03M | -$19.25 | 1 |
| Dec 2020 | $18.73M | $18.73M - $18.73M | -$18.73M | -$31.85 | 1 |
| Dec 2019 | $24.28M | $24.28M - $24.28M | -$24.28M | -$34.767 | 1 |
| Dec 2018 | $15.69M | $15.69M - $15.69M | -$15.69M | -$60.20 | 1 |
| Dec 2017 | $13.08M | $13.08M - $13.08M | -$13.08M | -$63.00 | 1 |
| Dec 2016 | $6.43M | $6.43M - $6.43M | -$6.43M | -$103.60 | 1 |